Aura Biosciences (AURA) Total Liabilities (2020 - 2026)
Aura Biosciences' (AURA) quarterly Total Liabilities came in at $30.4 million in Q1 2026, up 10.92% YoY from $27.4 million in Q1 2025, and down 6.42% on a QoQ basis from $32.5 million in Q4 2025.
Aura Biosciences (AURA) Total Liabilities (2020 - 2026) Analysis & Trends
Aura Biosciences (AURA) has 7 years of Total Liabilities data on file, last reported at $30.4 million in Q1 2026.
- Quarterly Total Liabilities rose 10.92% year-over-year to $30.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $30.4 million (up 10.92% YoY) and the FY2025 annual result came in at $32.5 million, up 6.5% from the prior year.
- Total Liabilities fell to $30.4 million in Q1 2026, from $32.5 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $33.4 million in Q3 2025 to a low of $5.3 million in Q1 2022.
- A 5-year average of $26.2 million and a median of $28.1 million in 2022 frame the typical range for Total Liabilities.
- The widest YoY moves for Total Liabilities: up 382.78% in 2023, down 0.16% in 2023.
- Tracing AURA's Total Liabilities over 5 years: stood at $28.4 million in 2022, then climbed by 3.09% to $29.2 million in 2023, then advanced by 4.47% to $30.5 million in 2024, then climbed by 6.5% to $32.5 million in 2025, then dropped by 6.42% to $30.4 million in 2026.
- The last three Total Liabilities figures came in at $30.4 million (Q1 2026), $32.5 million (Q4 2025), and $33.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.62 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 1.72 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 4.00 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 7.02 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 10.03 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.20 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.35 Bn |
| 10 | Aura Biosciences | 797.49 Mn | 729.65 Mn | - | 32.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 32.86 Mn |
| Mar 31, 2026 | 30.43 Mn |
| Dec 31, 2025 | 32.52 Mn |
| Sep 30, 2025 | 33.36 Mn |
| Jun 30, 2025 | 29.77 Mn |
| Mar 31, 2025 | 27.44 Mn |
| Dec 31, 2024 | 30.53 Mn |
| Sep 30, 2024 | 30.67 Mn |
| Jun 30, 2024 | 26.83 Mn |
| Mar 31, 2024 | 26.24 Mn |
| Dec 31, 2023 | 29.23 Mn |
| Sep 30, 2023 | 28.05 Mn |
| Jun 30, 2023 | 26.30 Mn |
| Mar 31, 2023 | 25.76 Mn |
| Dec 31, 2022 | 28.35 Mn |
| Sep 30, 2022 | 28.09 Mn |
| Jun 30, 2022 | 5.93 Mn |
| Mar 31, 2022 | 5.34 Mn |
| Dec 31, 2021 | 7.72 Mn |
| Sep 30, 2021 | 6.42 Mn |